You have 9 free searches left this month | for more free features.

palifermin

Showing 1 - 25 of 39

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Multiple Myeloma, Myelodysplastic Syndrome Trial in New York (biological, procedure, radiation, drug)

Active, not recruiting
  • Leukemia
  • +3 more
  • Palifermin
  • +6 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 23, 2023

Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Bethesda, Minneapolis (biological, drug,

Recruiting
  • Myelodysplastic Syndrome
  • +4 more
  • Rituximab
  • +6 more
  • Bethesda, Maryland
  • +1 more
Aug 20, 2022

T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)

Terminated
  • T-cell Non-Hodgkin Lymphoma
  • Boston, Massachusetts
  • +1 more
Jan 26, 2023

X-linked Severe Combined Immunodeficiency (XSCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

Suspended
  • X-linked Severe Combined Immunodeficiency (XSCID)
  • Palifermin
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Epidermolysis Bullosa Trial in Aurora, Chicago, New York (Palifermin, Fludarabine, Busulfan)

Terminated
  • Epidermolysis Bullosa
  • Palifermin
  • +5 more
  • Aurora, Colorado
  • +2 more
Aug 13, 2021

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, biological, drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Jan 12, 2023

Myeloma Trial in Houston (Palifermin, Dexamethasone, Gemcitabine)

Completed
  • Myeloma
  • Palifermin
  • +6 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 23, 2020

Lymphoma Trial in Houston (Gemcitabine, Busulfan, Melphalan)

Completed
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 13, 2019

X-Linked Combined Immunodeficiency Diseases Trial run by the NIAID (CD34+ HSCs transduced with the lentivirus vector, VSV-G

Unknown status
  • X-Linked Combined Immunodeficiency Diseases
  • CD34+ HSCs transduced with the lentivirus vector, VSV-G pseudotyped CL20-4i-EF1α-hγc-OPT
  • +2 more
  • Bethesda, Maryland
    Laboratory of Host Defenses (LHD), National Institute of Allergy
Dec 3, 2019

Lymphoma Trial in Houston (Lenalidomide, Vorinostat, Gemcitabine)

Terminated
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 26, 2019

Multiple Sclerosis Trial in Cambridge (Palifermin, Alemtuzumab)

Terminated
  • Multiple Sclerosis
  • Cambridge, Cambridgeshire, United Kingdom
    Addenbrooke's Hospital
Apr 26, 2019

Gastrointestinal Mucositis, Malignant Tumor Trial (Palifermin, Placebo)

Withdrawn
  • Gastrointestinal Mucositis
  • Malignant Neoplasm
  • Palifermin
  • Placebo
  • (no location specified)
Aug 3, 2018

Hematopoietic and Lymphoid Cell Tumor, Hematopoietic Cell Transplantation Recipient Trial in Duarte (procedure, drug, other,

Withdrawn
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Hematopoietic Cell Transplantation Recipient
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Dec 5, 2018

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplasia Trial in Indianapolis (radiation, drug, biological)

Terminated
  • Acute Myeloid Leukemia
  • +3 more
  • Total Body Irradiation
  • +4 more
  • Indianapolis, Indiana
    Indiana University Cancer Center
Mar 12, 2018

Mucositis, Head Neck Cancer Trial (Placebo, palifermin, Radiotherapy)

Completed
  • Mucositis
  • Head and Neck Cancer
  • Placebo
  • +3 more
  • (no location specified)
May 29, 2017

Head Neck Cancer, Mucositis, Pain Trial in Canada, United States (biological, drug, other, procedure, radiation)

Terminated
  • Head and Neck Cancer
  • +3 more
  • palifermin
  • +4 more
  • Scottsdale, Arizona
  • +47 more
Nov 28, 2017

Dysphagia, NSCLC, Lung Cancer Trial (Palifermin, Placebo, Radiotherapy)

Completed
  • Dysphagia
  • +2 more
  • Palifermin
  • +4 more
  • (no location specified)
Feb 2, 2017

Plasma Cell Leukemia in Remission, Plasma Cell Myeloma Trial in Duarte (procedure, drug, biological, other, radiation)

Withdrawn
  • Plasma Cell Leukemia in Remission
  • Plasma Cell Myeloma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Dec 11, 2017

Head Neck Cancer Trial (Placebo, Palifermin)

Completed
  • Head and Neck Cancer
  • Placebo
  • Palifermin
  • (no location specified)
Dec 14, 2016

Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome Trial in Bridgeport, New Haven (Palifermin)

Terminated
  • Toxic Epidermal Necrolysis
  • Stevens-Johnson Syndrome
  • Palifermin
  • Bridgeport, Connecticut
  • +1 more
Oct 6, 2016

Lymphoma Trial (drug, other, biological)

Withdrawn
  • Lymphoma
  • Palifermin
  • +12 more
  • (no location specified)
Apr 20, 2017

Mucositis, Solid Tumors, Stomatitis Trial (Placebo, palifermin, cisplatin chemo)

Completed
  • Mucositis
  • +4 more
  • Placebo
  • +3 more
  • (no location specified)
Aug 19, 2016

Leukemia, Lymphoma, Myeloma Trial in Houston (Busulfan, Gemcitabine, Melphalan)

Completed
  • Leukemia
  • +2 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Jun 1, 2016

Lymphoma Trial in Houston (Vorinostat, Gemcitabine, Busulfan)

Completed
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 17, 2015

Mucositis Trial (Palifermin)

Unknown status
  • Mucositis
  • Palifermin
  • (no location specified)
Dec 8, 2014